Report Information on US Apheresis Service Market Research by Service Type, by Application, by End User Forecast to 2035

Description

List of Tables

Report Information on US Apheresis Service Market Research by Service Type (Donor/Automated Apheresis, Therapeutic Apheresis, and Stem Cell Collection and Processing), by Application (Neurological Disorders, Autoimmune Disorders, Hematologic Disorders, Oncology, Metabolic Toxicology Disorders, Infectious Diseases, Cardiovascular Disorders, and Others), by End User (Hospitals, Blood Banks, Specialty Clinics, Research Laboratories, and Biotechnology Pharmaceutical Companies) Forecast to 2035

Overview of the Market

It is projected that the US apheresis services market would grow at a noteworthy rate of 8.47% between 2025 and 2035. A medical process known as apheresis involves taking blood from a patient or donor, separating out a particular component (such plasma, platelets, or white blood cells), and then reintroducing the remaining blood into the body. It is frequently employed for therapeutic objectives, including as collecting blood items for transfusions, such platelets or plasma, or eliminating excess components in certain disorders, such as leukemia's extra white blood cells.

The US apheresis market is expanding due to favorable reimbursement rules, the growing frequency of chronic diseases, and the growing demand for medicines generated from plasma. The market is further constrained by the high expense of procedures, safety issues with blood transfusions, and the need to find volunteer, unpaid donors. Nonetheless, the market will have future development prospects due to the rising need for apheresis and platelet-rich plasma therapy for pediatric and leukemia patients.

Segmentation of the Market

The US Apheresis Service Market has been divided into three segments based on the type of service: Stem Cell Collection and Processing, Therapeutic Apheresis, and Donor/Automated Apheresis.

Neurological Disorders, Autoimmune Disorders, Hematologic Disorders, Oncology, Metabolic Toxicology Disorders, Infectious Diseases, Cardiovascular Disorders, and Others are the segments of the US Apheresis Service Market based on application. In 2024, the market for hematologic disorders was the largest, and throughout the forecast period, the oncology category is expected to develop at the quickest rate.

Hospitals, Blood Banks, Specialty Clinics, Research Laboratories, and Biotechnology Pharmaceutical Companies are the end-user segments that make up the US Apheresis Service Market.

The US Apheresis Service Market has been divided into four regions: North, South, Midwest, and West. South held the biggest market share in 2024 and is expected to grow at the greatest compound annual growth rate (CAGR) of 9.63% during the forecast period, reaching USD 757.67 million by 2035.

Key Players

Versiti, Fresenius Medical Care, Carter BloodCare, ImpactLife, Mayo Clinic, The New York Blood Center (NYBC), The American Red, BioBridge Global, and San Diego Blood Bank (SDBB) are the major participants in the US apheresis services market.

1 EXECUTIVE SUMMARY

2 MARKET INTRODUCTION

2.1 DEFINITION
2.2 SCOPE OF THE STUDY
2.3 RESEARCH OBJECTIVE
2.4 MARKET STRUCTURE

3 RESEARCH METHODOLOGY

3.1 OVERVIEW
3.2 DATA FLOW
- 3.2.1 DATA MINING PROCESS
3.3 PURCHASED DATABASE:
3.4 SECONDARY SOURCES:
- 3.4.1 SECONDARY RESEARCH DATA FLOW:
3.5 PRIMARY RESEARCH:
- 3.5.1 PRIMARY RESEARCH DATA FLOW:
- 3.5.2 PRIMARY RESEARCH: NUMBER OF INTERVIEWS CONDUCTED
3.6 APPROACHES FOR MARKET SIZE ESTIMATION:
- 3.6.1 REVENUE ANALYSIS APPROACH
3.7 DATA FORECASTING
- 3.7.1 DATA FORECASTING TYPE
3.8 DATA MODELING
- 3.8.1 MICROECONOMIC FACTOR ANALYSIS:
- 3.8.2 DATA MODELING:
3.9 TEAMS AND ANALYST CONTRIBUTION

4 MARKET DYNAMICS

4.1 INTRODUCTION
4.2 DRIVERS
- 4.2.1 INCREASING PREVALENCE OF CHRONIC DISEASES
- 4.2.2 RISING DEMAND FOR PLASMA-DERIVED THERAPIES
- 4.2.3 FAVORABLE REIMBURSEMENT POLICIES
4.3 RESTRAINTS
- 4.3.1 HIGH PROCEDURE COSTS
- 4.3.2 SAFETY CONCERNS IN BLOOD TRANSFUSIONS
- 4.3.3 RECRUITMENT OF VOLUNTARY NON-REMUNERATED DONORS
4.4 OPPORTUNITY
- 4.4.1 INCREASING DEMAND FOR PLATELET-RICH PLASMA THERAPY
- 4.4.2 APHERESIS FOR LEUKEMIA AND PEDIATRIC PATIENTS

5 MARKET FACTOR ANALYSIS

5.1 PORTER'S FIVE FORCES MODEL
- 5.1.1 THREAT OF NEW ENTRANTS
- 5.1.2 BARGAINING POWER OF SUPPLIERS
- 5.1.3 THREAT OF SUBSTITUTES
- 5.1.4 BARGAINING POWER OF BUYERS
- 5.1.5 INTENSITY OF RIVALRY
5.2 IMPACT OF COVID-19 ON THE US APHERESIS MARKET

6 US APHERESIS SERVICE MARKET, BY SERVICE TYPE

6.1 OVERVIEW

7 US APHERESIS SERVICE MARKET, BY APPLICATION

7.1 OVERVIEW

8 US APHERESIS SERVICE MARKET, BY END USER

8.1 OVERVIEW

9 US APHERESIS SERVICE MARKET, BY REGION

9.1 OVERVIEW
9.2 NORTH
9.3 SOUTH
9.4 MIDWEST
9.5 WEST

10 COMPETITIVE LANDSCAPE

10.1 INTRODUCTION
10.2 MARKET SHARE ANALYSIS, 2024
10.3 COMPETITOR DASHBOARD
10.4 PUBLIC PLAYERS STOCK SUMMARY
10.5 COMPARATIVE ANALYSIS: KEY PLAYERS FINANCIAL
10.1 KEY DEVELOPMENTS & GROWTH STRATEGIES
- 10.1.1 FACILITY LAUNCH
- 10.1.2 ACQUISITION
- 10.1.3 PARTNERSHIP
- 10.1.4 TRANSITION

11 COMPANY PROFILES

11.1 VERSITI
- 11.1.1 COMPANY OVERVIEW
- 11.1.2 FINANCIAL OVERVIEW
- 11.1.3 SERVICES OFFERED
- 11.1.4 KEY DEVELOPMENTS
- 11.1.5 SWOT ANALYSIS
- 11.1.6 KEY STRATEGIES
11.2 FRESENIUS MEDICAL CARE AG
- 11.2.1 COMPANY OVERVIEW
- 11.2.2 FINANCIAL OVERVIEW
- 11.2.3 SERVICES OFFERED
- 11.2.4 KEY DEVELOPMENTS
- 11.2.5 SWOT ANALYSIS
- 11.2.6 KEY STRATEGIES
11.3 VITALANT
- 11.3.1 COMPANY OVERVIEW
- 11.3.2 FINANCIAL OVERVIEW
- 11.3.3 SERVICES OFFERED
- 11.3.4 KEY DEVELOPMENTS
- 11.3.5 SWOT ANALYSIS
- 11.3.6 KEY STRATEGIES
11.4 CARTER BLOODCARE
- 11.4.1 COMPANY OVERVIEW
- 11.4.2 FINANCIAL OVERVIEW
- 11.4.3 SERVICES OFFERED
- 11.4.4 KEY DEVELOPMENTS
- 11.4.5 KEY STRATEGIES
11.5 IMPACTLIFE
- 11.5.1 COMPANY OVERVIEW
- 11.5.2 FINANCIAL OVERVIEW
- 11.5.3 SERVICES OFFERED
- 11.5.4 KEY DEVELOPMENTS
- 11.5.5 KEY STRATEGIES
11.6 MAYO FOUNDATION FOR MEDICAL EDUCATION AND RESEARCH (MFMER)
- 11.6.1 COMPANY OVERVIEW
- 11.6.2 FINANCIAL OVERVIEW
- 11.6.3 SERVICES OFFERED
- 11.6.4 KEY DEVELOPMENTS
- 11.6.5 KEY STRATEGIES
11.7 NEW YORK BLOOD CENTER (NYBC)
- 11.7.1 COMPANY OVERVIEW
- 11.7.2 FINANCIAL OVERVIEW
- 11.7.3 SERVICES OFFERED
- 11.7.4 KEY DEVELOPMENTS
- 11.7.5 SWOT ANALYSIS
- 11.7.6 KEY STRATEGIES
11.8 THE AMERICAN NATIONAL RED CROSS
- 11.8.1 COMPANY OVERVIEW
- 11.8.2 FINANCIAL OVERVIEW
- 11.8.3 SERVICES OFFERED
- 11.8.4 KEY DEVELOPMENTS
- 11.8.5 SWOT ANALYSIS
- 11.8.6 KEY STRATEGIES
11.9 BIOBRIDGE GLOBAL
- 11.9.1 COMPANY OVERVIEW
- 11.9.2 FINANCIAL OVERVIEW
- 11.9.3 SERVICES OFFERED
- 11.9.4 KEY DEVELOPMENTS
- 11.9.5 KEY STRATEGIES
11.10 SAN DIEGO BLOOD BANK
- 11.10.1 COMPANY OVERVIEW
- 11.10.2 FINANCIAL OVERVIEW
- 11.10.3 SERVICES OFFERED
- 11.10.4 KEY DEVELOPMENTS
- 11.10.5 KEY STRATEGIES

12 DATA CITATIONS

LIST OF TABLES

TABLE 1 QFD MODELING FOR MARKET SHARE ASSESSMENT
TABLE 2 US APHERESIS SERVICE MARKET, BY SERVICE TYPE, 2019-2035 (USD MILLION)
TABLE 3 US APHERESIS SERVICE MARKET, FOR THERAPEUTIC APHERESIS, BY TYPE, 2019-2035 (USD MILLION)
TABLE 4 US APHERESIS SERVICE MARKET, BY APPLICATION, 2019-2035 (USD MILLION)
TABLE 5 US APHERESIS SERVICE MARKET, BY END USER, 2019-2035 (USD MILLION)
TABLE 6 US APHERESIS SERVICE MARKET, BY REGION, 2019-2035 (USD MILLION)
TABLE 7 NORTH: APHERESIS SERVICE MARKET, BY SERVICE TYPE 2019-2035 (USD MILLION)
TABLE 8 NORTH: APHERESIS SERVICE MARKET, FOR THERAPEUTIC APHERESIS, BY TYPE 2019-2035 (USD MILLION)
TABLE 9 NORTH: APHERESIS SERVICE MARKET, BY APPLICATION, 2019-2035 (USD MILLION)
TABLE 10 NORTH: APHERESIS SERVICE MARKET, BY END USER, 2019-2035 (USD MILLION)
TABLE 11 SOUTH: APHERESIS SERVICE MARKET, BY SERVICE TYPE 2019-2035 (USD MILLION)
TABLE 12 SOUTH: APHERESIS SERVICE MARKET, FOR THERAPEUTIC APHERESIS, BY TYPE 2019-2035 (USD MILLION)
TABLE 13 SOUTH: APHERESIS SERVICE MARKET, BY APPLICATION, 2019-2035 (USD MILLION)
TABLE 14 SOUTH: APHERESIS SERVICE MARKET, BY END USER, 2019-2035 (USD MILLION)
TABLE 15 MIDWEST: APHERESIS SERVICE MARKET, BY SERVICE TYPE 2019-2035 (USD MILLION)
TABLE 16 MIDWEST: APHERESIS SERVICE MARKET, FOR THERAPEUTIC APHERESIS, BY TYPE 2019-2035 (USD MILLION)
TABLE 17 MIDWEST: APHERESIS SERVICE MARKET, BY APPLICATION, 2019-2035 (USD MILLION)
TABLE 18 MIDWEST: APHERESIS SERVICE MARKET, BY END USER, 2019-2035 (USD MILLION)
TABLE 19 WEST: APHERESIS SERVICE MARKET, BY SERVICE TYPE 2019-2035 (USD MILLION)
TABLE 20 WEST: APHERESIS SERVICE MARKET, FOR THERAPEUTIC APHERESIS, BY TYPE 2019-2035 (USD MILLION)
TABLE 21 WEST: APHERESIS SERVICE MARKET, BY APPLICATION, 2019-2035 (USD MILLION)
TABLE 22 WEST: APHERESIS SERVICE MARKET, BY END USER, 2019-2035 (USD MILLION)
TABLE 23 FACILITY LAUNCH
TABLE 24 ACQUISITION
TABLE 25 PARTNERSHIP
TABLE 26 TRANSITION
TABLE 27 VERSITI: SERVICES OFFERED
TABLE 28 VERSITI: KEY DEVELOPMENTS
TABLE 29 FRESENIUS MEDICAL CARE AG: SERVICES OFFERED
TABLE 30 VITALANT: SERVICES OFFERED
TABLE 31 VITALANT: KEY DEVELOPMENTS
TABLE 32 CARTER BLOODCARE: SERVICES OFFERED
TABLE 33 CARTER BLOODCARE: KEY DEVELOPMENTS
TABLE 34 IMPACTLIFE: SERVICES OFFERED
TABLE 35 MAYO FOUNDATION FOR MEDICAL EDUCATION AND RESEARCH (MFMER): SERVICES OFFERED
TABLE 36 NEW YORK BLOOD CENTER (NYBC): SERVICES OFFERED
TABLE 37 THE AMERICAN NATIONAL RED CROSS: SERVICES OFFERED
TABLE 38 BIOBRIDGE GLOBAL: SERVICES OFFERED
TABLE 39 SAN DIEGO BLOOD BANK: SERVICES OFFERED

LIST OF FIGURES

FIGURE 1 US APHERESIS SERVICE MARKET: STRUCTURE
FIGURE 2 US APHERESIS MARKET: MARKET GROWTH FACTOR ANALYSIS (2025-2035)
FIGURE 3 DRIVER IMPACT ANALYSIS (2023-2035)
FIGURE 4 RESTRAINT IMPACT ANALYSIS (2023-2035)
FIGURE 5 PORTER'S FIVE FORCES ANALYSIS: US APHERESIS MARKET
FIGURE 6 US APHERESIS SERVICE MARKET SERVICE TYPE SEGMENT, 2024 & 2035 (USD MILLION)
FIGURE 7 US APHERESIS SERVICE MARKET, BY SERVICE TYPE, 2024 & 2035 (USD MILLION)
FIGURE 8 US APHERESIS SERVICE MARKET SHARE (%), BY SERVICE TYPE, 2024
FIGURE 9 US APHERESIS SERVICE MARKET, APPLICATION SEGMENT ATTRACTIVENESS, 2024 & 2035 (USD MILLION)
FIGURE 10 US APHERESIS SERVICE MARKET, BY APPLICATION, 2024 & 2035 (USD MILLION)
FIGURE 11 US APHERESIS SERVICE MARKET SHARE (%), BY APPLICATION, 2024
FIGURE 12 US APHERESIS SERVICE MARKET, APPLICATION SEGMENT ATTRACTIVENESS, 2024 & 2035 (USD MILLION)
FIGURE 13 US APHERESIS SERVICE MARKET, BY END USER, 2024 & 2035 (USD MILLION)
FIGURE 14 US APHERESIS SERVICE MARKET SHARE (%), BY END USER, 2024
FIGURE 15 US MARKET ANALYSIS: APHERESIS SERVICE MARKET, 2019-2035 (USD MILLION)
FIGURE 16 US APHERESIS SERVICE MARKET, BY REGION, 2024 & 2035 (USD MILLION)
FIGURE 17 US APHERESIS SERVICE MARKET SHARE (%), BY REGION, 2024
FIGURE 18 US APHERESIS SERVICES MARKET PLAYERS: COMPETITIVE ANALYSIS, 2024
FIGURE 19 COMPETITOR DASHBOARD: US APHERESIS SERVICES MARKET
FIGURE 20 VERSITI: SWOT ANALYSIS
FIGURE 21 FRESENIUS MEDICAL CARE AG: FINANCIAL OVERVIEW SNAPSHOT
FIGURE 22 FRESENIUS MEDICAL CARE AG: SWOT ANALYSIS
FIGURE 23 VITALANT: SWOT ANALYSIS
FIGURE 24 NEW YORK BLOOD CENTER (NYBC): SWOT ANALYSIS
FIGURE 25 THE AMERICAN NATIONAL RED CROSS: SWOT ANALYSIS